Embla Medical hf. (OSSUY)

Market Cap	1.77B -21.4%
Revenue (ttm)	997.24M +11.2%
Net Income	94.22M +22.1%
EPS	0.22 +22.4%
Shares Out	n/a
PE Ratio	19.49
Forward PE	16.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	4.230
Previous Close	4.150
Day's Range	4.230 - 4.230
52-Week Range	3.670 - 5.610
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 20, 2026

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. The Bracing and Supports segment provides os...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,500
• Stock Exchange: OTCMKTS
• Ticker Symbol: OSSUY

Financial Performance

In 2025, Embla Medical's revenue was $928.69 million, an increase of 8.63% compared to the previous year's $854.89 million. Earnings were $83.34 million, an increase of 22.05%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error